Healthcare and pharma procurement teams enter 2026 with rising spend, volatile supply markets, and higher expectations for performance.
For leaders, a good starting point for a new year is a procurement benchmarking report that shows how your KPIs compare with peers and where procurement benchmarks are actually being met.
The State of Spend Report, based entirely on real purchase orders, invoices, and supplier transactions, gives a unique view of how the industry actually operates. What's changing and where industry leaders outperform?
This article summarizes the trends, benchmarks, and KPIs procurement leaders most frequently look for as they plan 2026.
Full details, including category-level KPIs and distributions for top, average, and bottom performers in healthcare industry, are available in the complete State of Spend procurement benchmarking report.
Total healthcare spend has risen steadily since COVID-19 and remains above the 2022 Q1 baseline on an inflation-adjusted basis for both direct and indirect categories.
Key structural drivers are visible in the data and in the wider market:
Even small categories are strategic priorities. Fleet spend, for example, accounts for roughly 0.6% of revenue, but about 52% of that spend goes to fleet management services, signalling fleet modernization rather than simple operating cost (State of Spend, 2025).
Takeaway for 2026: Treat cost pressure as structural. Plans for 2026 should assume sustained spend growth rather than a return to pre-2022 levels.
AI adoption accelerated through 2025,
but the State of Spend data shows that results depend on digital maturity. Organizations that meet or exceed procurement best practices benchmarks in process design capture more AI value.
Common traits of higher-performing, AI-ready procurement functions:
In other words, AI performs best where processes are already standardized and data is structured. Where spend is fragmented, and PO discipline is weak, the same tools deliver much less impact.
Takeaway for 2026: AI amplifies well-structured procurement processes, but it does not fix fragmentation. Strengthen PO discipline, master data, and category governance before scaling AI.
Payment-term discipline is one of the fastest, most scalable levers for working-capital gains.
According to the State of Spend 2025 dataset, moving from bottom-performing payment behavior to best-in-class execution can unlock around 65k USD in working capital per 1M USD of spend.
This improvement comes from:
Small shifts in average days to pay, applied consistently across large spend bases, convert into meaningful cash benefits.
Based on real transaction data (2024Q3–2025Q2), Healthcare companies show the following Direct Invoice-to-Due performance:
Indirect categories show wider performance spreads, reflecting more variability in terms of discipline:
The table below summarizes the payment terms by L2 Category and working capital improvement opportunities in Healthcare.
Takeaway for 2026: Payment terms will likely play a larger role in cash-flow management than in prior years. Treat payment terms as an integral part of the healthcare and pharma procurement strategy, not just a finance concern.
The 2025 State of Spend dataset highlights a group of procurement KPIs that consistently separate top-performing teams from the rest.
These metrics have the strongest impact on cost, cash flow, process efficiency, and resilience.
PO coverage is one of the clearest indicators of procurement process control.
Higher PO coverage is strongly associated with:
For healthcare and pharma procurement in 2026, high PO coverage means critical spend flows through governed channels, reducing compliance risk. Using governed channels also supports audit readiness and provides finance and leadership with a reliable view of costs amid ongoing price pressure and regulatory scrutiny.
Across major indirect categories, the State of Spend shows:
These differences show where operational discipline is strongest (e.g., MRO, IT) and where unmanaged or spot buying remains common (e.g., Professional Services, Logistics).
The granular L3 cut provides a clearer sense of how inconsistent process use can be at the line-item level:
Categories with low PO coverage often correspond to fragmented supplier bases, decentralized buying behavior, or unclear intake channels.
As healthcare organizations prepare for another year of cost pressure, these gaps are where procurement can tighten process control with relatively low friction.
Raising L2 and L3 coverage even modestly improves auditability and provides cleaner data for category strategy, forecasting, and payment-term execution.
Spend per invoice captures how well categories and buying channels are designed and governed.
Higher spend per invoice usually indicates:
In 2026, this KPI matters because organizations need scalable purchasing models that absorb inflation and volatility without adding manual workload.
Higher spend per invoice signals that guided buying, catalogs, and contracts are working, which frees capacity for category strategy, supplier risk work, and collaboration with CMOs, CROs, and other strategic partners.
From a benchmark perspective, the State of Spend 2025 Healthcare dataset shows a clear spread in Direct Spend per Invoice between performance tiers.
Top-performing Healthcare companies reach an average Direct Spend per Invoice of 6.4k USD, median performers sit at 3.6k USD, and bottom performers at 1.5k USD.
The number of active suppliers directly affects risk and leverage. The median remains high, especially compared with more consolidated industries.
This KPI influences:
In the State of Spend dataset, top performers operate with around 0.6k suppliers per 1b USD of spend and an average 1.6m USD spend per supplier in Direct Spend.
Average performers manage roughly 1.3k suppliers per 1b USD (about 798k USD per supplier), while bottom performers are up at 2k suppliers per 1b USD, with only 486k USD per supplier.
On Indirect Spend, fragmentation is more visible. For top performers, roughly 8.1k suppliers handle each 1b USD of spend, translating to about 126k USD per supplier.
At the average level, 1b USD is spread across about 13.3k suppliers, dropping the figure to roughly 75k USD per supplier.
For bottom performers, the same 1b USD is split among around 19.3k suppliers, so only about 52k USD flows through each supplier.
Supply markets are still exposed to geopolitical tension, logistics volatility, and tightening quality requirements. A large, fragmented supplier base makes it harder to monitor risk, maintain consistent pricing, and keep up with qualification and oversight.
Invoice-to-due timing links operational speed with cash discipline. It is particularly important in categories where payment terms are strategic.
This KPI helps you understand:
In 2026, boards are pushing harder on working capital while suppliers ask for reliability and, in some cases, faster cash to cope with their own cost and financing pressures.
Stable invoice-to-due timing lets healthcare and pharma companies manage cash deliberately without signalling risk or unreliability to critical partners.
A practical next step is to benchmark your own KPIs against industry peers in the State of Spend report.
Using these KPIs as a common language with finance, supply chain, and business leaders makes it easier to agree on priorities, track impact during 2026, and adjust as markets move.
The full State of Spend report provides the benchmarks and distributions needed to decide where procurement is already leading and where targeted changes can unlock the next step of value.